AIC
TMO icon

Argus Investors Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Argus Investors Counsel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Sell
928
-3
-0.3% -$1.44K 0.36% 66
2026
Q1 		$458K Sell
931
-78
-8% -$42.3K 0.41% 59
2025
Q4 		$585K Buy
+1,009
New +$571K 0.47% 53
2025
Q3 		– Sell
-3,065
Closed -$1.24M – 116
2025
Q2 		$1.24M Buy
3,065
+59
+2% +$24.7K 0.88% 34
2025
Q1 		$1.5M Buy
3,006
+11
+0.4% +$5.96K 1.14% 28
2024
Q4 		$1.56M Sell
2,995
-38
-1% -$20.9K 1.04% 31
2024
Q3 		$1.88M Sell
3,033
-31
-1% -$18.4K 1.22% 29
2024
Q2 		$1.69M Buy
3,064
+60
+2% +$34.4K 1.04% 30
2024
Q1 		$1.75M Sell
3,004
-3
-0.1% -$1.68K 1.07% 29
2023
Q4 		$1.6M Hold
3,007
– – 1.02% 40
2023
Q3 		$1.52M Sell
3,007
-542
-15% -$289K 1.1% 36
2023
Q2 		$1.85M Buy
3,549
+682
+24% +$368K 1.28% 26
2023
Q1 		$1.65M Sell
2,867
-14
-0.5% -$7.89K 1.25% 28
2022
Q4 		$1.59M Buy
2,881
+67
+2% +$35.5K 1.27% 30
2022
Q3 		$1.43M Buy
2,814
+31
+1% +$17.3K 1.27% 30
2022
Q2 		$1.51M Sell
2,783
-185
-6% -$102K 1.12% 45
2022
Q1 		$1.75M Buy
2,968
+284
+11% +$163K 1.12% 48
2021
Q4 		$1.79M Buy
2,684
+233
+10% +$145K 1.08% 50
2021
Q3 		$1.4M Buy
2,451
+165
+7% +$90.6K 0.92% 53
2021
Q2 		$1.15M Sell
2,286
-204
-8% -$96.3K 0.47% 56
2021
Q1 		$1.14M Sell
2,490
-179
-7% -$85.4K 0.46% 53
2020
Q4 		$1.24M Buy
2,669
+83
+3% +$38.9K 0.55% 51
2020
Q3 		$1.14M Buy
2,586
+185
+8% +$76.4K 0.47% 50
2020
Q2 		$870K Buy
2,401
+611
+34% +$205K 0.42% 51
2020
Q1 		$508K Buy
1,790
+68
+4% +$21.4K 0.3% 51
2019
Q4 		$559K Buy
1,722
+156
+10% +$47.3K 0.25% 55
2019
Q3 		$456K Buy
1,566
+52
+3% +$14.9K 0.22% 59
2019
Q2 		$445K Buy
1,514
+359
+31% +$98.9K 0.21% 60
2019
Q1 		$316K Sell
1,155
-21
-2% -$5.23K 0.15% 69
2018
Q4 		$263K Buy
+1,176
New +$276K 0.14% 67

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Argus Investors Counsel's TMO Position: Q2 2026 in Review

Argus Investors Counsel reduced its Thermo Fisher Scientific (TMO) stake by 0.32% in Q2 2026, selling an estimated $1.44K and leaving 928 shares worth $465K. The position accounts for 0.36% of the portfolio, ranked #66.

Argus Investors Counsel first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.88M in Q3 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Argus Investors Counsel held 928 shares of Thermo Fisher Scientific worth $465K as of Q2 2026.
  • Argus Investors Counsel sold 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.36% of Argus Investors Counsel's portfolio in Q2 2026, its #66 holding.
  • Argus Investors Counsel first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Argus Investors Counsel's Thermo Fisher Scientific position peaked at $1.88M in Q3 2024.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Argus Investors Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.